BRIANA NORTON PAFF: Open Payments
NPI 1811566276 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$174 in 9 payments from 7 companies in 2025. Trend: 2023 $158 · 2024 $603 · 2025 $174
Food & beverage: $174
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $43 |
| Alnylam Pharmaceuticals Inc. | 1 | $26 |
| CVRx, Inc. | 2 | $25 |
| BridgeBio Pharma, Inc. | 1 | $24 |
| Azurity Pharmaceuticals, Inc. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $15 |
Products named: ELIQUIS, AMVUTTRA, Barostim Neo System, Attruby, EDARBI, NEXLETOL.
Industry payments across FL — which companies pay providers there.
